For the treatment of respiratory disease (Histophilus somni,
Mannheimia haemolytica and Pasteurella multocida), and
interdigital necrobacillosis (Bacteroides melaninogenicus,
Fusobacterium necrophorum, Fusobacterium nucleatum,
Prevotella bivia and Prevotella oralis) due to bacteria
susceptible to ceftiofur and associated with pain and/or
pyrexia and/or inflammation.